Roger Schultz has joined Signature Genomic Laboratories as a laboratory director.
Schultz was previously associate director of cytogenetics of Veripath Laboratories at the University of Texas Southwestern. He holds a PhD in genetics from Michigan State University and completed a postdoc at Stanford University School of Medicine.
Thomas O'Connor has been appointed senior vice president of sales and marketing at SQI Diagnostics.
He will be based in the US and will be responsible for building SQI's multiplex immunoassay platform franchise in North America and Europe, the Toronto-based company said.
O'Connor has held executive sales positions at Luminex, Beckman Coulter, and Exagen Diagnostics.
Genetix has tapped Stephen Game to fill the new position of head of research and development, a job he will begin in November. Game currently is a technology manager of cellular science at GE Healthcare Life Sciences, where he is involved in strategic development and product portfolio management. He arrived at GE Healthcare when it purchased Amersham Biosciences, where Game was department director of cell biology.
Bio Nano Consulting has appointed Mike Fisher to be director of business development and to manage a new contract with the UK. Fisher recently was the British government’s North American advisor on life sciences for UK Trade and Investment. He founded the Northwest Genetics Knowledge Park and helped develop a biotech cluster in the northwest of England.